Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where C. Degli Esposti is active.

Publication


Featured researches published by C. Degli Esposti.


Radiotherapy and Oncology | 2016

PO-0875: Multivariable models for urinary symptoms at 6-24 months after radical RT of prostate cancer

F. Palorini; T. Rancati; A. Cicchetti; I. Improta; C. Cozzarini; V. Casanova Borca; C. Degli Esposti; Pierfrancesco Franco; E. Garibaldi; G. Girelli; A. Maggio; R. Micera; M. Palombarini; A. Pierelli; E. Pignoli; N. Simoni; V. Vavassori; S. Villa; Riccardo Valdagni; C. Fiorino

Conclusion: The delivery of a voxel by voxel iso-effective plan, if different RBE models are employed, is not feasible; it is however possible to minimize differences in dose deposited in the target. Dose prescription is a clinical task which ultimately depends only on the radiation oncologist clinical decision; in this study we made an attempt to avoid systematic errors which could potentially compromise tumor control. Initial clinical data on local control of adenoid cystic carcinoma treated in our facility confirms the validity of this approach.


International Journal of Radiation Oncology Biology Physics | 2015

Multivariable Models Predicting Specific Patient-Reported Acute Urinary Symptoms After Radiation Therapy for Prostate Cancer: Results of a Cohort Study

T. Rancati; C. Cozzarini; I. Improta; F. Palorini; E. Garibaldi; Pierfrancesco Franco; B. Avuzzi; C. Degli Esposti; G. Girelli; C. Iotti; V. Vavassori; Riccardo Valdagni; C. Fiorino


Radiotherapy and Oncology | 2017

OC-0038: Patterns in ano-rectal dose maps and the risk of late toxicity after prostate radiotherapy

E. Onjukka; C. Fiorino; F. Palorini; A. Cicchetti; I. Improta; C. Cozzarini; C. Degli Esposti; Pietro Gabriele; Riccardo Valdagni; G. Gagliardi; T. Rancati


Radiotherapy and Oncology | 2017

PO-0850: Predicting late fecal incontinence risk after RT for prostate cancer:external independent validation

A. Cicchetti; B. Avuzzi; T. Rancati; F. Palorini; Claudio Stucchi; Giovanni Fellin; Pietro Gabriele; V. Vavassori; C. Degli Esposti; C. Cozzarini; C. Fiorino; Riccardo Valdagni


Radiotherapy and Oncology | 2017

PO-0729: Normal Tissue Complication Probability for late urinary toxicities after RT for prostate cancer

F. Palorini; A. Cicchetti; T. Rancati; C. Cozzarini; B. Avuzzi; C. Degli Esposti; Pierfrancesco Franco; E. Garibaldi; G. Girelli; C. Iotti; V. Vavassori; Riccardo Valdagni; C. Fiorino


Radiotherapy and Oncology | 2017

EP-1152: Intraoperative radiotherapy for early breast cancer: a monocentric experience

A. Baldissera; L. Giaccherini; I. Marinelli; A. Parisi; G. Siepe; O. Martelli; Fabrizio Salvi; D. Balestrini; C. Degli Esposti; I. Ammendolia; G. Tolento; V. Panni; G. Macchia; F. Deodato; S. Cilla; Alessio Giuseppe Morganti; G. Frezza


International Journal of Radiation Oncology Biology Physics | 2017

Incidence of Late Severe Urinary Symptoms after Radical IMRT for Prostate Cancer: Effect of Bladder Doses and Hypofractionation

F. Palorini; A. Cicchetti; T. Rancati; C. Cozzarini; B. Avuzzi; D. Cante; C. Degli Esposti; E. Garibaldi; C. Iotti; F. Munoz; V. Vavassori; Riccardo Valdagni; C. Fiorino


Radiotherapy and Oncology | 2016

OC-0535: How patient-reported urinary symptoms predict impairment of urinary QoL from RT for prostate cancer

C. Cozzarini; F. Badenchini; T. Rancati; G. Girelli; Pietro Gabriele; C. Degli Esposti; Pierfrancesco Franco; V. Vavassori; M. Galeandro; C. Bianconi; C. Improta; F. Palorini; Riccardo Valdagni; C. Fiorino


Radiotherapy and Oncology | 2016

EP-1371: Role of 11C choline PET/CT in the management of prostate cancer patients with biochemical relapse

R. Frakulli; G. Siepe; M. Ntreta; S. Cammelli; G. Tolento; G. Macchia; F. Deodato; A. Arcelli; F. Bertini; L. Ronchi; G. Di Gioia; V. Dionisi; M. Pieri; G. Martorana; Stefano Fanti; D. Balestrini; C. Degli Esposti; A. Galuppi; Alessio Giuseppe Morganti; G. Frezza


International Journal of Radiation Oncology Biology Physics | 2016

What Happens to Testosterone Levels After Radical Radiation Therapy for Prostate Cancer

B. Avuzzi; C. Cozzarini; T. Rancati; I. Improta; F. Palorini; F. Badenchini; C. Iotti; V. Vavassori; G. Girelli; C. Degli Esposti; Riccardo Valdagni; C. Fiorino

Collaboration


Dive into the C. Degli Esposti's collaboration.

Top Co-Authors

Avatar

C. Cozzarini

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

C. Fiorino

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

T. Rancati

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

F. Palorini

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Pierelli

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

I. Improta

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge